Related Experiment Videos

Possible participation of macrophage inflammatory protein 2 in neutrophil infiltration in allergic inflammation in

Y Q Xiao1, J I Tanabe, T Edamatsu

  • 1Department of Pathophysiological Biochemistry, Faculty of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.

Insights

Macrophage inflammatory protein 2 (MIP-2) drives neutrophil infiltration during rat allergic inflammation. Neutralizing antibodies against MIP-2 effectively suppressed this inflammatory response, highlighting MIP-2's crucial role.

Area of Science:

  • Immunology
  • Inflammation Research
  • Chemoattractant Cytokines

Background:

  • Neutrophil infiltration is a hallmark of allergic inflammation.
  • The specific role of macrophage inflammatory protein 2 (MIP-2) in this process requires further elucidation.

Purpose of the Study:

  • To investigate the role of rat macrophage inflammatory protein 2 (MIP-2) in neutrophil infiltration during allergic inflammation.
  • To assess the efficacy of anti-MIP-2 antibodies in modulating this inflammatory response.

Main Methods:

  • Recombinant rat MIP-2 was produced using a glutathione-S-transferase (GST) fusion protein expression vector in E. coli.
  • A polyclonal antibody against rat MIP-2 was generated in rabbits.
  • An air pouch-type allergic inflammation model in rats was utilized.
  • Neutrophil infiltration and chemotactic activity were measured in pouch fluid and conditioned media.

Main Results:

  • Neutrophil infiltration into the air pouch increased over time following antigen challenge.
  • Neutrophil chemotactic activity in pouch fluid was significantly reduced by anti-MIP-2 antibody.
  • Leukocyte-conditioned media exhibited time-dependent neutrophil chemotactic activity, which was neutralized by anti-MIP-2 antibody.
  • Administration of anti-MIP-2 antibody into the air pouch suppressed neutrophil infiltration.

Conclusions:

  • Macrophage inflammatory protein 2 (MIP-2) is a key mediator of neutrophil infiltration in rat allergic inflammation.
  • Targeting MIP-2 with specific antibodies represents a potential therapeutic strategy for allergic inflammatory conditions.

Related Concept Videos